EASD 2018 Conference Review - reviewed by Associate Professor Neale Cohen

In this review:

Results from CARMELINA – linagliptin in T2D
Empagliflozin as adjunctive to insulin therapy in T1D: The EASE Trials
Albiglutide and CV outcomes in patients with T2D and CVD
The PIONEER trials - effect of oral semaglutide in T2D
CV safety and efficacy of lorcaserin in overweight or obese patients
Management of hyperglycaemia in type 2 diabetes
Efficacy and safety of LY3298176 in patients with T2D
Assessment of an implantable CGM system through 180 days in an adolescent population with T1D
Advantages of combined stimulation of GLP-1 and GIP receptors in T2D?
Nasal glucagon: a viable alternative to treat hypoglycaemia in adults with T1D

Please login below to download this issue (PDF)